An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
about
Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathwayTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsCurrent perspectives on systems immunology approaches to rheumatic diseases.A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisGene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositisImportance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritisDisease-associated pathophysiologic structures in pediatric rheumatic diseases show characteristics of scale-free networks seen in physiologic systems: implications for pathogenesis and treatment.Safety, Tolerability, and Immunogenicity of InterferonsAssessing the human immune system through blood transcriptomics.Defining TNF-α- and LPS-induced gene signatures in monocytes to unravel the complexity of peripheral blood transcriptomes in health and disease.A genomic approach to human autoimmune diseases.Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatmentTranscription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosisDermatomyositis as a complication of interferon-α therapy: a case report and review of the literatureInterferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseasesMycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.Sterol intermediates of cholesterol biosynthesis inhibit hair growth and trigger an innate immune response in cicatricial alopecia.Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseasesType 1 interferons and myositis.Cutaneous dermatomyositis in the era of biologicals.Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetesJuvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Association of IRF5 polymorphisms with activation of the interferon alpha pathwayAdipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measuresSensors of the innate immune system: their link to rheumatic diseases.Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy.Type I interferon pathway in adult and juvenile dermatomyositis.The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.Involvement of dendritic cells in autoimmune diseases in children.An interferon response gene expression signature is activated in a subset of medulloblastomasThe genetics of human autoimmune disease: A perspective on progress in the field and future directions.Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityThe type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease courseWiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.Endotoxin tolerance in monocytes can be mitigated by α2-interferonElevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.Monocyte enhancers are highly altered in systemic lupus erythematosus.Microarray-based identification of novel biomarkers in IL-1-mediated diseases.
P2860
Q24611933-386A6777-8373-460E-815E-A45215B8E5A7Q26796546-2CFF5691-0DFE-49BB-A7D9-4CA247C23DB4Q27687400-A6C13847-1F72-402E-BE9C-521D1A115602Q28257957-174D1C5F-74F6-47A7-A075-EA8B5BFE9435Q28287170-9F36A7F9-9E65-4D45-9849-6187DD135AA9Q28743723-075CD286-C6B6-41C8-B1F0-EDDC8313A842Q33411566-616DA060-88E5-42EF-B321-3110082AB597Q33435810-A5EE14C8-D161-49C1-87E1-3EE693F4D06FQ33629522-BAAECA6A-5BA2-47D6-A03B-5C6CEF82ADDAQ33635438-8A51C75D-B92B-49A6-8657-F37CECB60C6FQ33762839-FDEC9B9C-A7BE-476C-B173-4854A6BC2154Q33873657-B821BA2E-CA51-4ED8-913E-A907D477F886Q33921278-3E103AAF-D62F-4B42-923B-8DA4ACAA3690Q34091332-51173F26-0F66-42EE-99C0-FFC10B6EF659Q34123569-92B76296-7C3E-441A-8140-5DBBBC868269Q34185599-AEEB8AC6-2516-4B7F-9464-A7F36C4C4018Q34299630-BCE7C306-C59E-414E-89C8-7640A67D6ED6Q34346280-6D53D6C7-B282-4F91-8B0E-741D9221CEB5Q34350190-A4EDD21C-EC5C-4041-AF9A-7FFE6C26BC46Q34501531-E7BF0A10-EB36-4E9C-AD92-D887D119D4A5Q34693197-583D2CD4-FBE2-4EE9-8418-1CB8F967CDDAQ35009335-D55F919F-6F78-4ECB-AE10-79D95FF2661AQ35102479-F9715F5E-6BDA-4831-AFB1-C0AE8999E3EBQ35540694-DC350EC6-7928-458D-89AB-9E06401402BDQ35623130-86A32A76-1E3A-49AA-90D3-8F27D6FDCAEBQ35681780-FB62BF7C-29D3-48C6-9498-62B5841CB189Q35876136-6147976C-4935-425E-B0DB-0D330C12D5ABQ35907790-26B31917-1CBD-4500-9E00-F9D3E213B7F1Q35911498-F43C4154-30ED-46DE-9D22-15742CB1AA36Q35946403-DECCC37D-3805-4B7F-BE61-DBE203918EC1Q36199866-E89A3AE9-2B5B-4C8D-96BA-4C8781EF5EC6Q36236745-11FB2EFA-92DE-428F-BE4D-F1D442AE0479Q36245680-17A20E64-F9F6-4662-A86A-53C7AA1BCDD6Q36338717-586F77CE-DBBE-4D0B-AF84-85610D29E836Q36434501-AA6B1B24-A983-469A-A699-A6668CB19968Q36603542-539D0086-9F74-4E10-8C62-436BFA66E93FQ36607876-7A1FC99D-9285-4E76-BB04-EFD91D1A8904Q36656406-EA8D7F0B-03CB-4C05-87C3-C9C84FC780C7Q36892681-C5C15EA3-2A3F-4F93-A998-606B82CF18D4Q37013467-ED98E9EE-33BC-4136-96E3-2467260E571D
P2860
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
An interferon signature in the ...... sociated with disease activity
@ast
An interferon signature in the ...... sociated with disease activity
@en
An interferon signature in the ...... sociated with disease activity
@nl
type
label
An interferon signature in the ...... sociated with disease activity
@ast
An interferon signature in the ...... sociated with disease activity
@en
An interferon signature in the ...... sociated with disease activity
@nl
prefLabel
An interferon signature in the ...... sociated with disease activity
@ast
An interferon signature in the ...... sociated with disease activity
@en
An interferon signature in the ...... sociated with disease activity
@nl
P2093
P2860
P1433
P1476
An interferon signature in the ...... sociated with disease activity
@en
P2093
Ann M Reed
Catherine A Slattery
Emily C Baechler
Jason W Bauer
Jill Novitzke
Karl J Espe
Steven R Ytterberg
Timothy W Behrens
Ward A Ortmann
P2860
P2888
P356
10.2119/2006-00085.BAECHLER
P407
P577
2007-01-01T00:00:00Z
P5875
P6179
1068964971